Article may be outdated

This article is 5 days old. Some details may have changed since publication.

Mirage News·3 min read·hard

Targeting Immune System to Treat Endometriosis?

Targeting Immune System to Treat Endometriosis?
✦AI Summary

Researchers have identified TREM2-expressing macrophages as a potential therapeutic target for endometriosis, a chronic inflammatory disease. The study suggests these immune cells contribute to disease progression by impairing the body's natural defense mechanisms.

Why it matters

This discovery could lead to more effective treatments for endometriosis, which affects 200 million women and currently lacks reliable long-term management options.

✦Dive DeeperCreate a free account to unlock

Study elucidates how immune cells contribute to disease progression in endometriosis and identifies a potential future therapeutic target.

Affecting 200 million women of reproductive age, endometriosis is a chronic inflammatory disease that causes pain, infertility, and increased ovarian cancer risk. Hormone therapies are often used to manage pain and prevent the growth of uterine-lining-like tissue outside of the uterus, but these therapies can be ineffective and lead to recurrence. In a new study, published by Wiley in Advanced Science , researchers identified TREM2 + macrophages as a potential future target for endometriosis therapies.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in